The following table summarizes the components of the purchase consideration (in thousands): (Details) - Upsher-Smith Laboratories, LLC [Member] $ in Thousands |
Jun. 30, 2023
USD ($)
|
|---|---|
| Business Acquisition [Line Items] | |
| Closing cash consideration | $ 22,174 |
| Inventory adjustment payment liability | 1,348 |
| Deferred payment liability | 3,000 |
| Purchase price to be allocated | $ 26,522 |
| X | ||||||||||
- Definition Amount of adjustment to business combination consideration upon the determination of the value of acquired inventory. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|